SEARCH

SEARCH BY CITATION

References

  • 1
    Locksley RM, Killeen N & Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487501.
  • 2
    Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C & Smith CA (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673682.
  • 3
    Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5, 157163.
  • 4
    Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104, 155162.
  • 5
    Abdulghani J & El-Deiry WS (2010) TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets 14, 10911108.
  • 6
    Yang A, Wilson NS & Ashkenazi A (2010) Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. Curr Opin Cell Biol 22, 837844.
  • 7
    Gonzalvez F & Ashkenazi A (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29, 47524765.
  • 8
    Pop C, Fitzgerald P, Green DR & Salvesen GS (2007) Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 46, 43984407.
  • 9
    Wachmann K, Pop C, van Raam BJ, Drag M, Mace PD, Snipas SJ, Zmasek C, Schwarzenbacher R, Salvesen GS & Riedl SJ (2010) Activation and specificity of human caspase-10. Biochemistry 49, 83078315.
  • 10
    Sprick MR & Walczak H (2004) The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 1644, 125132.
  • 11
    Falschlehner C, Emmerich CH, Gerlach B & Walczak H (2007) TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 39, 14621475.
  • 12
    Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388, 190195.
  • 13
    Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR & Ashkenazi A (2009) Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137, 721735.
  • 14
    Rossin A, Derouet M, Abdel-Sater F & Hueber AO (2009) Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. Biochem J 419, 185192, et seq.
  • 15
    Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF, Totpal K et al. (2007) Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 13, 10701077.
  • 16
    Shirley S, Morizot A & Micheau O (2011) Regulating TRAIL receptor-induced cell death at the membrane: a deadly discussion. Recent Pat Anticancer Drug Discov 6, 311323.
  • 17
    Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM & Hao C (2007) Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res 67, 69466955.
  • 18
    Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L & Pintzas A (2007) Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 6, 25912599.
  • 19
    Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J et al. (2011) Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. Carcinogenesis 32, 4251.
  • 20
    Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schütze S, Peter ME & Chan AC (2006) The role of receptor internalization in CD95 signaling. EMBO J 25, 10091023.
  • 21
    Matarrese P, Manganelli V, Garofalo T, Tinari A, Gambardella L, Ndebele K, Khosravi-Far R, Sorice M, Esposti MD & Malorni W (2008) Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells. Biochem J 413, 467478.
  • 22
    Schütze S & Schneider-Brachert W (2009) Impact of TNF-R1 and CD95 internalization on apoptotic and antiapoptotic signaling. Results Probl Cell Differ 49, 6385.
  • 23
    Edelmann B, Bertsch U, Tchikov V, Winoto-Morbach S, Perrotta C, Jakob M, Adam-Klages S, Kabelitz D & Schütze S (2011) Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J 30, 379394.
  • 24
    Reinehr R, Sommerfeld A, Keitel V, Grether-Beck S & Haüssinger D (2008) Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes. J Biol Chem 283, 22112222.
  • 25
    Kohlhaas SL, Craxton A, Sun XM, Pinkoski MJ & Cohen GM (2007) Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem 282, 1283112841.
  • 26
    Akazawa Y, Mott JL, Bronk SF, Werneburg NW, Kahraman A, Guicciardi ME, Meng XW, Kohno S, Shah VH, Kaufmann SH et al. (2009) Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology 136, 23652376, e1–7.
  • 27
    Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8, 917929.
  • 28
    Werner G, Hagenmaier H, Drautz H, Baumgartner A & Zähner H (1984) Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo) 37, 110117.
  • 29
    Zeidan YH & Hannun YA (2010) The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr Mol Med 10, 454466.
  • 30
    Dumitru CA & Gulbins E (2006) TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 25, 56125625.
  • 31
    Stancevic B & Kolesnick R (2010) Ceramide-rich platforms in transmembrane signaling. FEBS Lett 584, 17281740.
  • 32
    Voelkel-Johnson C, Hannun YA & El-Zawahry A (2005) Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein. Mol Cancer Ther 4, 13201327.
  • 33
    MacFarlane M, Cohen GM & Dickens M (2000) JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem J 348 (Pt 1), 93101.
  • 34
    Werneburg NW, Bronk SF, Guicciardi ME, Thomas L, Dikeakos JD, Thomas G & Gores GJ (2012) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2). J Biol Chem 287, 2442724437.
  • 35
    Oberle C, Huai J, Reinheckel T, Tacke M, Rassner M, Ekert PG, Buellesbach J & Borner C (2010) Lysosomal membrane permeabilization and cathepsin release is a Bax/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes. Cell Death Differ 17, 11671178.
  • 36
    Wattiaux R, Wattiaux-de Coninck S, Thirion J, Gasingirwa MC & Jadot M (2007) Lysosomes and Fas-mediated liver cell death. Biochem J 403, 8995.
  • 37
    Spes A, Sobotic B, Turk V & Turk B (2012) Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines. Biol Chem 393, 14171431.
  • 38
    Dumitru CA, Carpinteiro A, Trarbach T, Hengge UR & Gulbins E (2007) Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis 12, 15331541.
  • 39
    Li X, Han WQ, Boini KM, Xia M, Zhang Y & Li PL (2013) TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice. J Mol Med (Berl) 91, 2536.
  • 40
    White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L & Voelkel-Johnson C (2009) Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28, 11321141.
  • 41
    Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L, Schwabe JW, Cain K & MacFarlane M (2012) A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 47, 291305.
  • 42
    Schleich K, Warnken U, Fricker N, Oztürk S, Richter P, Kammerer K, Schnölzer M, Krammer PH & Lavrik IN (2012) Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell 47, 306319.
  • 43
    Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan JP, Lill J & Ashkenazi A (2012) TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 48, 888899.
  • 44
    Cursi S, Rufini A, Stagni V, Condo I, Matafora V, Bachi A, Bonifazi AP, Coppola L, Superti-Furga G, Testi R et al. (2006) Src kinase phosphorylates caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J 25, 18951905.
  • 45
    Alvarado-Kristensson M, Melander F, Leandersson K, Ronnstrand L, Wernstedt C & Andersson T (2004) p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 199, 449458.
  • 46
    Peng C, Cho YY, Zhu F, Zhang J, Wen W, Xu Y, Yao K, Ma WY, Bode AM & Dong Z (2011) Phosphorylation of caspase-8 (Thr-263) by ribosomal S6 kinase 2 (RSK2) mediates caspase-8 ubiquitination and stability. J Biol Chem 286, 69466954.